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Background. Cardiovascular disease (CVD) is the leading cause of death among American Indians. It is not known if symptoms
of insomnia are associated with CVD in this population. Methods. We examined 449 American Indians aged ≥55 years from the
Native Elder Care Study. The main outcome-of-interest was self-reported CVD. Results. Short sleep duration, daytime sleepiness,
and diﬃculty falling asleep were positively associated with CVD after adjusting for demographic, lifestyle, and clinical risk factors.
Compared with a sleep duration of 7h, the multivariable odds ratio (OR) (95% conﬁdence interval [CI]) of CVD among those
with sleep duration ≤5h was 2.89 (1.17–7.16). Similarly, the multivariable OR (95% CI) of CVD was 4.45 (1.85–10.72) and 2.60
(1.25–5.42) for daytime sleepiness >2handdiﬃculty falling asleep often/always. Conclusion. Symptoms of insomnia including
short sleep duration, daytime sleepiness, and diﬃculty falling asleep are independently associated with CVD in American Indians
aged ≥55 years.
1.Introduction
Sleep complaints are common in older adults [1]a n dm o r e
than half of the older adults in a large population-based
study had complaints related to inadequate sleep [2]. Re-
cent studies have shown that sleep disturbances related to
insomnia including short [3–5]o rl o n g[ 4, 5] sleep duration,
daytime sleepiness [6], and diﬃculty falling asleep [3, 7]
are associated with cardiovascular disease (CVD). Several
prospective and cross-sectional studies have examined the
association between sleep duration and CVD [3–5, 8–13].
However, there is limited information on the association
betweensleepdurationandCVDinelderlypopulations[3,9,
11]. Further, studies that examined the association between
sleepdisturbancesincludingshorterorlongersleepduration,
daytime sleepiness, diﬃculty falling asleep, and CVD among
elderly adults were conducted in speciﬁc populations includ-
ing women [9], men [14], non-Hispanic whites [3, 7, 11],
or Japanese [11]. To our knowledge, no previous study
has reported the association between insomnia symptoms
and CVD in older American Indian adults. Although the
multiracial Sleep Heart Health Study (SHHS) reported that
sleep-disordered breathing was associated with heart failure,
no subgroup analysis by race or ethnicity was provided in
that report [15]. Among American Indians, CVD mortality
ratesequalorexceednationalAllRacesrates[16]andCVDis
the leading cause of death beginning at age 45 as opposed to
age65inthegeneralpopulation[17].Further,theprevalence
oftraditionalCVDriskfactors,includingdiabetes,hyperten-
sion, and dyslipidemia, is on the rise among American Indi-
ans [18]. However, it is not clear if insomnia symptoms con-
tribute to the rising prevalence of CVD in this population.2 Journal of Environmental and Public Health
In this context, we examined the association between sleep
duration, daytime sleepiness, and diﬃculty falling asleep and
CVD in a population-based sample of American Indians.
2. Methods
The data for this study was collected as part of the Native
Elder Care Study, a cross-sectional study of disability among
older American Indians. Detailed selection of study popula-
tion and methods has been reported previously [19, 20]. In
brief, a random sample of 633 American Indians aged ≥55
years was drawn from a list of 1,430 individuals provided by
tribal enrollment records. Of the 583 eligible participants,
505 participated in the baseline survey (86.6% response
rate). After excluding those with missing information on
sleep variables (n = 14) and other variables included in the
multivariable model (n = 42), 449 subjects were included
in the ﬁnal analysis. Ethics approval was obtained from the
tribe’s institutional review board, Tribal Council, and Elder
Council. This secondary data analysis was approved by the
West Virginia University Institutional Review Board.
2.1. Assessment of CVD. The main outcome of interest was
CVD deﬁned as a physician diagnosis of heart attack, angina,
heart failure, or stroke. This was determined by a “yes” re-
sponse to the following four questions: “since age 55 has
a doctor told you that you had angina, or heart attack, or
congestive heart failure, or “stroke”?
2.2. Assessment of Exposure. Sleep duration, daytime sleepi-
ness, and diﬃculty falling asleep were assessed from a
questionnaire. Sleep duration for the 12-hour time period in
night was assessed from the question “on average, how long
do you sleep per night?” The response coded in hours was
categorizedintoﬁvegroupsforanalysis:≤5,6,7,8,≥9hours.
In addition to night time sleep duration, we also assessed
24-hour sleep duration from the question, “how many total
hours do you sleep in an average 24-hour period?” The
response categorized into the same ﬁve groups as night time
sleep duration. Daytime sleepiness for the 12-hour daytime
period was assessed from the question “How often do you
fall asleep during the day against your will [17]?” As almost
everyone in this elderly cohort reported feeling sleepy at least
foranhourduringthedaytime,theresponsewascategorized
into three groups: 1, 2, >2h o u r s .D i ﬃculty falling asleep in
the night was assessed from the question “How often do you
have diﬃculty falling asleep or staying asleep?” The response
categorized into 3 groups: never, sometimes, often/always.
Information on demographic, lifestyle, personal, and
medical history was assessed from an interviewer-adminis-
tered questionnaire. Education was recorded as the highest
number of years of schooling completed and was categorized
into below high school, high school, and above high school
education. Current smokers were deﬁned as those who
answered aﬃrmatively to the question “Do you currently
smoke cigarettes?” Current alcohol drinking was deﬁned as
drinking alcohol everyday regardless of quantity. Physical
activity was deﬁned as engaging in physical activities such
as running, swimming, aerobics, gardening, or walking for
exercise. Symptoms of depression were assessed using the
Center for Epidemiologic Studies depression Scale (CES-D)
[21], a multidimensional screening instrument for major or
clinical depression. In CES-D, each of the 20 response items
is coded on a scale of 0–3 with the total scores ranging from
0–60. Depression was deﬁned as a score of ≥16 on the CES-
D scale. Presence of diabetes mellitus, hypertension, cancer,
chronic pain, and back pain were ascertained by a “yes” re-
sponse to the following ﬁve questions: “Since age 55 has a
doctor told that you had diabetes, or high blood pressure, or
cancer, or back pain, or chronic pain syndrome? Height was
measured in centimeters using a measuring tape and weight
in kilograms using a weighing scale. Body mass index (BMI)
was calculated as weight in kilograms divided by the square
of height in meters.
2.3.StatisticalAnalysis. Weﬁrstperformeddescriptivestatis-
tics for all variables. All analyses were performed incorporat-
ing the sampling weights to account for the oversampling of
agedpeople.Wethenexaminedtheassociationbetweencate-
goriesofsleepduration(7hasthereference),daytimesleepi-
ness (1h as the reference), and diﬃculty falling asleep (never
as the reference) and CVD in two logistic regression models
separatelyforeachsleepdisturbance:(1)adjustedforageand
sex, (2) additionally adjusted for education (<high school,
high school, above high school), current smoking (absent,
present), current alcohol consumption (absent, present),
physical activity (absent, present), BMI (kg/m2), diabetes
(absent, present), hypertension (absent, present), depression
(absent, present), cancer (absent, present), chronic pain (ab-
sent, present), and back pain (absent, present). As the three
sleep disturbances might be intercorrelated with each other,
in a separate analysis, we included all three sleep variables
simultaneously in the multivariable model and repeated the
analysis. We performed tests for trend using the categories
of sleep variables as ordinal variables in the corresponding
multivariable model. All statistical analyses were performed
using SAS version 9.1.
3. Results
The mean age of the study population was 65.9y (SD =
8.5y) and 62% were female. The prevalence of various
comorbidities was high in this elderly population (diabetes
= 40.9%, hypertension = 56.6%, depression = 13.8%, cancer
= 9.5%, chronic pain = 11.2%, and back pain = 34.9%)
(data not shown). Table 1 shows the baseline characteristics
of the study population by gender. Women were less likely
to be current drinkers and more likely to report diﬃculty
falling asleep than men. There was no signiﬁcant diﬀerence
(P = 0.9) in the reported average sleep duration between
men and women (6.8 versus 6.9h). The prevalence of
each sleep disturbance is presented in Figure 1. 21.3% of
the participants reported sleeping 7h and 14.8% of the
participants reported sleeping ≤5h. 6.7% of the participants
reported having daytime sleepiness >2h and 16.6% of the
participants had diﬃculty falling asleep often/always.Journal of Environmental and Public Health 3
Table 1: Baseline characteristics of the study population by gender.
Characteristics Men (n = 163) Women (n = 286) P-value
Age (years) 64.9 (8.0) 66.4 (8.7) 0.06
Education categories (%) 0.5
Below high school 29.1 33.2
High school 30.9 32.2
Above high school 40.0 34.6
Current smoker (%) 21.8 27.7 0.2
Current drinker (%) 19.6 8.1 0.0003
Moderate physical activity (%) 66.8 57.6 0.05
Body mass index (kg/m2) 30.0 (5.4) 29.9 (6.7) 0.9
Diabetes mellitus (%) 36.8 43.5 0.2
Hypertension (%) 54.8 57.7 0.5
Cancer (%) 10.6 15.9 0.1
Depression (%) 8.2 10.4 0.4
Chronic pain (%) 11.4 11.1 0.9
Back pain (%) 30.3 37.7 0.1
Night sleep duration (hours) 6.8 (1.7) 6.9 (1.6) 0.9
Daytime sleepiness (hours) 1.6 (0.7) 1.4 (0.6) 0.05
Diﬃculty falling asleep (hours) 1.7 (0.8) 1.9 (0.9) 0.003
∗Data presented are percentages or mean values (standard deviation), as appropriate for the variable.
Table 2: Association between sleep variables and cardiovascular disease.







≤55 8 29.2 3.51 (1.55–7.95) 2.89 (1.17–7.16)
6 101 17.6 1.55 (0.71–3.42) 1.32 (0.56–3.09)
79 8 12.6 1 (referent) 1 (referent)
8 145 22.1 1.85 (0.89–3.85) 1.67 (0.76–3.66)
≥94 7 18.5 1.46 (0.54–3.93) 1.15 (0.38–3.53)
Frequency of daytime sleepiness, h
1 253 14.3 1 (referent) 1 (referent)
2 161 22.6 1.53 (0.91–2.57) 1.33 (0.76–2.34)
>23 5 54.6 6.06 (2.71–13.52) 4.45 (1.85–10.72)
P-trend <0.0001 0.003
Diﬃculty falling asleep
Never 200 14.8 1 (referent) 1 (referent)
Sometimes 178 20.0 1.60 (0.92–2.78) 1.23 (0.68–2.25)
Often or always 71 31.9 3.39 (1.76–6.53) 2.60 (1.25–5.42)
P-trend 0.0004 0.02
Abbreviations: CI: conﬁdence interval; OR: odds ratio.
∗Unweighted sample size
†Adjusted for age (years), sex (men, women), education (<high school, high school, >high school), current smoking (absent, present), current alcohol con-
sumption(absent,present),physicalactivity(absent,present),bodymassindex(kg/m2),diabetes(absent,present),hypertension(absent,present),depression
(absent, present), cancer (absent, present), chronic pain (absent, present) and back pain (absent, present).
In univariate analysis, older age, below high school edu-
cation, diabetes, hypertension, cancer, chronic pain, and
back pain were associated with CVD; older age, current
smoking, depression, chronic pain, and back pain were sig-
niﬁcantly associated with sleep duration ≤5h(allP<0.05).
Table 2 shows the relationship between the sleep distur-
bances and CVD after adjusting for potential confounders.
The prevalence of CVD was highest among those who
reportedsleeping≤5handlowestamongthosewhoreported































































































































Figure 1: Prevalence of sleep disturbances in the study population.
between sleep duration ≤5h and CVD in both the age, sex-
adjusted, and the multivariable model additionally adjusted
for education, current smoking, current alcohol drinking,
physical activity, diabetes mellitus, hypertension, depression,
cancer, chronic pain, and back pain. The prevalence of CVD
increased with increasing categories of daytime sleepiness
(P-trend < 0.0001) and daytime sleepiness >2h was signiﬁ-
cantlyassociatedwithCVDinboththemodels.Similarly,the
prevalence of CVD increased with increasing categories of
diﬃcultyfallingasleep(P-trend = 0.006)andtheassociation
between diﬃculty falling asleep often/always was signiﬁcant
in both the models.
In a supplementary analysis, when we included all
three sleep disturbances simultaneously in the multivariable
model, although all 3 sleep disturbances showed a positive
magnitude of association with CVD, only the association of
daytimesleepiness>2hwithCVDwasstatisticallysigniﬁcant
(OR [95%] = 4.16 [1.67–10.32] for daytime sleepiness >2h)
and not for sleep duration or diﬃculty falling asleep (OR
[95%] = 1.90 [0.68–5.34] for sleep duration ≤5h and 2.00
[0.84–4.76] for diﬃculty falling asleep). In a second supple-
mentary analysis, when we assessed the association between
24h sleep duration and CVD, the pattern of association was
similartothatofnighttimesleepduration.Comparedwitha
sleepdurationof7h,themultivariableoddsratio(OR)(95%
conﬁdence interval [CI]) of CVD was 5.37 (1.94–14.91) for
sleep duration ≤5h and 2.26 (0.92–5.54) for >8h.
4. Discussion
In a population-based study of American Indian adults
aged ≥55 years, short sleep duration, daytime sleepiness,
and diﬃculty falling asleep were signiﬁcantly associated
with CVD independent of age, sex, education, currentJournal of Environmental and Public Health 5
smoking, current alcohol consumption, physical activity,
BMI, diabetes, hypertension, depression, cancer, chronic
pain, and back pain. To our knowledge, this is the ﬁrst
study to separately report the association between various
sleep characteristics and CVD among American Indians.
Ourﬁndingsofassociationsbetweensleepduration,daytime
sleepiness, diﬃculty falling asleep, and CVD are consistent
with previous studies that reported a similar association
in older Hispanic and non-Hispanic whites and African
Americans [3, 4, 6, 7] and extend the association to middle-
aged and older adults in the American Indian population.
In the current study, sleep duration ≤5h was associated
with CVD. Similar to our report, sleep duration <6h was
associated with CVD among 1506 men and women aged
≥55 years who participated in the 2003 Sleep in America
poll [3] and sleep duration <7.5h was associated with inci-
dent CVD among 1255 elderly adults with hypertension in
Japan [13]. Few studies have documented a “U” shaped
association between sleep duration and CVD [4, 5, 8]a n d
CVD mortality [22, 23]. A recent meta-analysis including
15 prospective studies documented a positive association
between both short and long durations of sleep and CVD
[8]. Both short and long durations of sleep were associated
with CVD among adults aged >60 years in the National
Health Interview Survey 2005 [4] and with coronary heart
disease among female health professionals aged 45–65 years
in the Nurses’ Health study [5]. In contrast to our study,
few studies have documented an association between long
duration of sleep and CVD [9, 12]. Sleep duration ≥9h o u r s
was shown to be associated with CVD among a large cohort
of postmenopausal women in the Women’s Health Initiative
[9] and 3,430 middle-aged Chinese adults in Taiwan [12].
In the current study, daytime sleepiness and diﬃculty
falling asleep were associated with CVD similar to previous
reports. In the Cardiovascular Health Study including 5,888
whites and African Americans [6], daytime sleepiness was
associatedwithCVD,andinanearlierstudy,diﬃcultyfalling
asleepwasassociatedwithanginainthesamepopulation[7].
Daytime sleepiness was associated with stroke among 7,844
adults who participated in the NHANES-I followup study in
the US and a large cohort of men aged 55–69 years in the UK
[14].
An association between symptoms of insomnia and CVD
isbiologicallyplausible.Shortsleepduration,daytimesleepi-
ness, and diﬃculty falling asleep through metabolic and
endocrine dysfunctions lead to impaired glucose tolerance,
increased insulin resistance, enhanced sympathetic activity,
and increased blood pressure with resultant CVD [24, 25].
Studieshavealsodocumentedanassociationbetweeninsom-
nia symptoms and risk factors of CVD including diabetes
[3, 26], hypertension [27], obesity [28] dyslipidemia [29],
and metabolic syndrome [30].
Thestrengthsofthecurrentstudyincludeitspopulation-
based nature and the availability of data on potential con-
founders.Ourstudyhasseverallimitations.First,sleephabits
were self-reported and the associated measurement error
might have resulted in a nondiﬀerential misclassiﬁcation of
exposure.Second,weassesseddaytimesleepinessusingasin-
gle question rather than the standard Epworth Sleepiness
Score (ESS). However, daytime sleepiness assessed using a
single question is comparable to that measured using ESS
[31] and several epidemiological studies have assessed day-
time sleepiness using a single question similar to ours [32,
33]. Third, it is possible that our results may be biased by
residual confounding from unmeasured variables including
sleep disordered breathing (SDB) that play a role in CVD.
Fourth, although the sample size was adequate to detect an
overall association, it was insuﬃcient to perform subgroup
analysis and to explore eﬀect modiﬁcations. Fifth, because of
thecross-sectionalnatureofthestudy,wecannotinfercausal
associations.
In conclusion, our study shows that short sleep duration,
daytime sleepiness, and diﬃculty falling asleep were associ-
ated with CVD among American Indians. If conﬁrmed by
future prospective studies, our ﬁndings may have impor-
tant implications for targeting sleep habits in intervention
programs intended to reduce the burden of CVD among
American Indians.
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